We are live on ! Find out more
NC

Nicholas Company Portfolio holdings

AUM $5.1B
1-Year Est. Return 8.43%
This Fund
S&P 500
This Quarter Est. Return
-3.15%
1 Year Est. Return
+8.43%
3 Year Est. Return
+54.31%
5 Year Est. Return
+77.46%
10 Year Est. Return
+337.16%
AUM
$5B
AUM Growth
-$230M
Cap. Flow
-$29.8M
Cap. Flow %
-0.6%
Top 10 Hldgs %
20.01%
Holding
221
New
4
Increased
43
Reduced
107
Closed
7

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$43.4M
2
DXCM icon
DexCom
DXCM
+$31.1M
3
TXN icon
Texas Instruments
TXN
+$11.8M
4
TECH icon
Bio-Techne
TECH
+$11.3M
5
GMED icon
Globus Medical
GMED
+$7.15M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$42.5M
2
CPRT icon
Copart
CPRT
+$12.4M
3
PODD icon
Insulet
PODD
+$12.1M
4
TWLO icon
Twilio
TWLO
+$10.1M
5
CTAS icon
Cintas
CTAS
+$8.88M

Sector Composition

Rank Sector Weight
1 Technology 31.98%
2 Healthcare 17.02%
3 Consumer Discretionary 12.67%
4 Industrials 12.3%
5 Financials 10.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRL icon
101
Charles River Laboratories
CRL
$11.3B
$11.8M 0.24%
59,986
– –
RMD icon
102
ResMed
RMD
$31.1B
$11.6M 0.23%
78,645
+11,385
+17% +$2.06M
TECH icon
103
Bio-Techne
TECH
$11.2B
$11.5M 0.23%
168,609
+142,510
+546% +$11.3M
DPZ icon
104
Domino's
DPZ
$11.9B
$11.4M 0.23%
29,980
– –
CNS icon
105
Cohen & Steers
CNS
$4.2B
$11.1M 0.22%
176,935
-205
-0.1% -$13K
HOLX
106
DELISTED
Hologic
HOLX
$10.8M 0.22%
155,565
– –
ICFI icon
107
ICF International
ICFI
$1.5B
$10.8M 0.22%
89,155
+20
+0% +$2.5K
WBS icon
108
Webster Financial
WBS
$12.3B
$10.1M 0.2%
251,760
-52,250
-17% -$2.22M
ROAD icon
109
Construction Partners
ROAD
$5.88B
$9.51M 0.19%
260,083
-12,155
-4% -$401K
CB icon
110
Chubb
CB
$140B
$9.43M 0.19%
45,310
-195
-0.4% -$39.4K
QLYS icon
111
Qualys
QLYS
$4.76B
$9.29M 0.19%
60,921
– –
WEN icon
112
Wendy's
WEN
$1.46B
$9.16M 0.18%
448,585
+21,360
+5% +$446K
CSCO icon
113
Cisco
CSCO
$443B
$8.95M 0.18%
166,500
-13,840
-8% -$747K
DSGX icon
114
Descartes Systems
DSGX
$6.68B
$8.84M 0.18%
120,410
– –
PBH icon
115
Prestige Consumer Healthcare
PBH
$2.47B
$8.67M 0.17%
151,565
-10,555
-7% -$638K
ABBV icon
116
AbbVie
ABBV
$465B
$8.6M 0.17%
57,695
-250
-0.4% -$36.7K
UL icon
117
Unilever
UL
$142B
$8.58M 0.17%
154,311
-618
-0.4% -$35.7K
MDT icon
118
Medtronic
MDT
$112B
$8.57M 0.17%
109,370
-507,095
-82% -$42.5M
SPSC icon
119
SPS Commerce
SPSC
$2.55B
$8.56M 0.17%
50,169
-65
-0.1% -$11.5K
ETN icon
120
Eaton
ETN
$141B
$8.37M 0.17%
39,260
-4,565
-10% -$984K
APD icon
121
Air Products & Chemicals
APD
$65.5B
$8.28M 0.17%
29,205
-3,800
-12% -$1.11M
ABT icon
122
Abbott
ABT
$187B
$8.21M 0.16%
84,790
-370
-0.4% -$38.9K
AZN icon
123
AstraZeneca
AZN
$269B
$8.15M 0.16%
60,205
-263
-0.4% -$35.9K
CVX icon
124
Chevron
CVX
$382B
$8.12M 0.16%
48,155
-200
-0.4% -$32.3K
LECO icon
125
Lincoln Electric
LECO
$14.1B
$8.12M 0.16%
44,650
-185
-0.4% -$35.3K
3 4
5
6 7

Similar funds

VT
Vise Technologies New York $5.09B AUM 22.62% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CTC
Central Trust Company Jefferson City, Missouri $5.08B AUM 25.65% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Nicholas Company's Q3 2023 Portfolio in Review

As of Q3 2023, Nicholas Company held 221 positions worth $5B, down 4.4% from $5.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 5%. Nicholas Company opened 4 new positions and exited 7, leaving the 221-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nicholas Company's largest Q3 2023 buy was Stryker: 151,415 shares worth $41.4M.
  • Nicholas Company added most to DexCom in Q3 2023, an estimated $31.1M increase.
  • Nicholas Company's biggest Q3 2023 reduction was Medtronic, cutting an estimated $42.5M.
  • Nicholas Company fully exited Insulet in Q3 2023, selling an estimated $12.1M.
  • Nicholas Company's ten largest holdings make up 20% of its $5B portfolio in Q3 2023.
  • Nicholas Company opened 4 new positions and closed 7 in Q3 2023.
  • Nicholas Company's portfolio value fell 4.4% quarter-over-quarter to $5B.

Based on Nicholas Company's 13F filing for Q3 2023, filed 13 Nov 2023.